Beraprost is classified as a prostacyclin analog. It has been studied for the treatment of pulmonary hypertension and for use in avoiding reperfusion injury. Reference standards of Beraprost API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => 4-((1R,2R,3aS,8bS)-2-Hydroxy-1-((E)-4-methyl-3-oxooct-1-en-6-yn-1-yl)-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]benzofuran-5-yl)butanoic Acid [catalogue_number] => PA 02 1791001 [category_ids] => ,75,76,78,70,82, [chemical_name] => [weight] => 396.48 [form] => C24H28O5 [cas] => NA [pslug] => 4-1r-2r-3as-8bs-2-hydroxy-1-e-4-methyl-3-oxooct-1-en-6-yn-1-yl-2-3-3a-8b-tetrahydro-1h-cyclopenta-b-benzofuran-5-yl-butanoic-acid-pa021791001 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 02 1791001
CAS :
Molecular Formula : C24H28O5
Molecular Weight : 396.48
stdClass Object ( [pname] => 4-((1R,2R,3aS,8bS)-2-Hydroxy-1-((3S,Z)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl)-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]benzofuran-5-yl)butanoic Acid [catalogue_number] => PA 02 1791000 [category_ids] => ,75,76,78,70,82, [chemical_name] => [weight] => 398.5 [form] => C24H30O5 [cas] => NA [pslug] => 4-1r-2r-3as-8bs-2-hydroxy-1-3s-z-3-hydroxy-4-methyloct-1-en-6-yn-1-yl-2-3-3a-8b-tetrahydro-1h-cyclopenta-b-benzofuran-5-yl-butanoic-acid-pa021791000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 02 1791000
Molecular Formula : C24H30O5
Molecular Weight : 398.5
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
